| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash used in operating activities | -19,223 | -13,218 |
| Purchases of property and equipment | 16 | 9 |
| Net cash used in investing activities | -16 | -9 |
| Proceeds from exercise of warrants | 0 | 0 |
| Net cash provided by financing activities | 0 | 0 |
| Net decrease in cash, cash equivalents and restricted cash | -19,239 | -13,227 |
| Cash and cash equivalents at beginning of period | 71,194 | - |
| Cash and cash equivalents at end of period | 51,955 | - |
ATOSSA THERAPEUTICS, INC. (ATOS)
ATOSSA THERAPEUTICS, INC. (ATOS)